Although further studies for underlying mechanism are needed to verify the exact effects of GLIS1 expression of CAFs on OSC metastasis, these results give a promising indication that CAFs derived GLIS1 may function as a therapeutic target for OSCs. Here, GLIS1 is linked to osteopathia striata with cranial sclerosis.